PR Newswire - IND Application for NTS071, Nutshell Therapeutics'...
SHANGHAI, May 4, 2025 /PRNewswire/ -- On April 23, 2025, Nutshell Therapeutics ( Shanghai ) Co., LTD. received IND clearance from the FDA to initiate Phase 1 clinical trial in the Uni...
Read More

ภาษาไทย
English